Lift Global Ventures plc, led by the well-known stock market commentator, CEO Zak Mir, announced its £1.7m raise with the company, set to list on the Aquis Stock Exchange Growth Market (AQSE) in London, UK, in January 2022
In today interview, Alan Green from Novus Comms speaks with Zak to better understand the rationale behind the new listing and what investors can expect from the management team.
Zak Mir, CEO of Lift Global Ventures, said, “The run-up to the fundraise and listing on Aquis early in the New Year is an exciting period for Lift Global Ventures. The financial media and technology space remains one of opportunity for the Company.”
Zak Mir, CEO of Lift Global Ventures, said, “The run-up to the fundraise and listing on Aquis early in the New Year is an exciting period for Lift Global Ventures. The financial media and technology space remains one of opportunity for the Company.”
LFT is an investor in the financial media and technology space. It intends to hunt in the back garden of the Directors’ experience which runs the gamut of service providers and investment houses on the stock market.
The company is an investor in the financial media and technology space. It intends to hunt in the back garden of the Directors’ experience which runs the gamut of service providers and investment houses on the stock market.
For further information please contact:
For further information please contact:
Lift Global Ventures plc
Zak Mir, Chief Executive Officer (+44 7867 527659)
Novum Securities Limited, AQSE Corporate Adviser and Broker
David Coffman / Colin Rowbury (+44 207 399 9400)
Listen On
Also Listen
-
Zak Mir talks to Ryan Mee, CEO of Fulcrum Metals
Zak Mir talks to Ryan Mee, CEO of Fulcrum Metals, in the wake of the Panther Met -
Zak Mir talks to Segun Lawson, President & CEO of Thor Explorations
Zak Mir talks to Segun Lawson, CEO of Thor Explorations. The company provided an -
Zak Mir talks to Mark Routh, CEO of Prospex Energy
Zak Mir talks to Mark Routh, CEO of Prospex Energy, an AIM-quoted investment com -
Transforming Biotech: Insights from Tim McCarthy, CEO of ImmuPharma
ImmuPharma PLC (AIM: IMM) CEO Tim McCarthy spoke with Zak Mir. In the world of b